Neuroinflammatory Diseases

The grounding supports several causes or triggers, including CNS injury, infection, toxicity, and autoimmunity. It also notes that neuroinflammation can arise from genetic variations in CNS cells or from peripheral immune cell involvement, and that protein aggregates can induce inflammatory responses.

The core mechanism is activation and dysregulation of CNS immune cells, especially microglia and astrocytes, with release of cytokines and other inflammatory mediators. The literature also links neuroinflammation with oxidative stress, blood-brain barrier dysfunction, peripheral immune cell infiltration, and impaired clearance or propagation of misfolded protein aggregates. Chronic or excessive inflammation can worsen neuronal injury and contribute to neurodegeneration.

Supported risk factors include CNS injury, infection, toxicity, and autoimmunity. The grounding also indicates susceptibility associated with genetic variation in CNS cells, peripheral immune cell infiltration, aging, oxidative stress, and the presence of misfolded protein aggregates.

The supplied grounding does not support a single standard treatment for neuroinflammatory diseases as a category. It only indicates that the literature covers drug therapy and therapy broadly, and discusses potential therapeutic targeting of microglia, oxidative stress, and inflammatory pathways rather than a defined class-based standard of care.